Clinical Trial Categories
  • Age & Physical Activity (1)
  • Alzheimer's Disease (7)
  • Arthritis (3)
  • Asthma (1)
  • Cancer - Bladder (1)
  • Cancer - Brain & CNS (16)
  • Cancer - Breast (8)
  • Cancer - Colon/Colorectal (2)
  • Cancer - Digestive System (2)
  • Cancer - Female Reproductive (8)
  • Cancer - Gastric (1)
  • Cancer - Kidney (2)
  • Cancer - Leukemia (6)
  • Cancer - Liver (1)
  • Cancer - Lung (3)
  • Cancer - Lymphoma (27)
  • Cancer - Melanoma (15)
  • Cancer - Mesothelioma (2)
  • Cancer - Myeloma (10)
  • Cancer - Other (5)
  • Cancer - Ovarian (2)
  • Cancer - Pancreas (2)
  • Cancer - Peritoneal (5)
  • Cancer - Prostate (12)
  • Cancer - Sarcoma (1)
  • Cancer - Stomach (1)
  • Cancer - Testicular (1)
  • Cancer - Tissue (6)
  • Crohn's Disease (3)
  • Dermatitis (2)
  • Dermatomyositis (1)
  • Healthy (6)
  • Hepatitis C (2)
  • HIV (4)
  • HPV (1)
  • Hypercholesterolemia (1)
  • Immune Disease - Autoimmune (9)
  • Immune Disease - Primary (2)
  • Immune Disease - Secondary (6)
  • Infectious Disease (2)
  • Inflammatory Disease (3)
  • Kidney Transplant (1)
  • Liver Disease (2)
  • Lupus Erythematosus (3)
  • Multiple Sclerosis (3)
  • Neurodegenerative (1)
  • OX40 (1)
  • Parkinson's Disease (1)
  • Pediatric (3)
  • Transplant (2)

KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Wednesday
Nov031999

NCT00001512

Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines

Conditions: B Cell Lymphoma, Follicular Lymphoma, Lymphoma
Sponsors: National Cancer Institute (NCI)
Phase I

Date: DateNovember 3, 1999 | Reference3 References
Categories CategoryCancer - Lymphoma
Tags , , ,
Monday
Nov011999

NCT00003638

Vaccine Therapy in Treating Women With Metastatic Breast Cancer

Conditions: Breast Cancer
Sponsors: Oncothyreon Canada Inc.
Phase III

Date: DateNovember 1, 1999
Categories CategoryCancer - Breast
Tags , ,
Monday
Nov011999

NCT00003357

Vaccine Therapy Plus QS21 in Treating Women With Breast Cancer Who Have No Evidence of Disease

Conditions: Breast Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase I

Date: DateNovember 1, 1999
Categories CategoryCancer - Breast
Tags ,
Monday
Nov011999

NCT00002787

Vaccine Therapy Plus GM-CSF in Treating Patients With Multiple Myeloma Undergoing Bone Marrow or Peripheral Stem Cell Transplantation

Conditions: Multiple Myeloma, Plasma Cell Neoplasm
Sponsors: Fred Hutchinson Cancer Research Center, National Cancer institute (NCI)
Phase I

Date: DateNovember 1, 1999
Categories CategoryCancer - Myeloma, CategoryCancer - Tissue
Tags , , ,
Monday
Nov011999

NCT00003819

Vaccine Therapy Plus QS21 in Treating Patients With Progressive Prostate

Conditions: Prostate Cancer
Sponsors: Memorial Sloan-Kettering Cancer Center, National Cancer Institute (NCI)
Phase I

Date: DateNovember 1, 1999
Categories CategoryCancer - Prostate
Tags , ,
Page 1 ... 12 13 14 15 16